Slide 3 summarises well and footnote 6 I read as " we already have non-binding offers for US and China market" waiting for board approval" I reckon there must be negotiations going on behind the doors before the curtain will be lifted and announcement will be made to the market. Recruitment Phase for phase-2 is progressing. I believe R&D reimbursement will also follow after these commercialisation deals. Keep believing in DXB200
Ann: Dimerix Presents at ASX Small & Mid-Cap Conference, page-3
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.010(2.38%) |
Mkt cap ! $239.6M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 40.5¢ | $705.9K | 1.678M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 113371 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 1375 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |